Synthesizing a Genetic Sensor Based on CRISPR-Cas9 for Specifically Killing p53-Deficient Cancer Cells

Area of Science:

• Oncology
• Molecular Biology
• Genetic Engineering

Background:

• Cancer remains a significant global health challenge.
• The p53 protein is crucial in cancer development and is frequently mutated.
• Existing methods for detecting wild type p53 (WTP53) and distinguishing it from mutant forms are limited.

Purpose of the Study:

• To design and construct a genetic sensor for detecting WTP53 expression.
• To develop a novel cancer treatment strategy utilizing the p53 sensor.

Main Methods:

• Development of a p53 genetic sensor to monitor WTP53 levels.
• Integration of the p53 sensor with diphtheria toxin via CRISPR-Cas9 gene editing.
• Construction of a p53 sensor system designed to target p53-deficient cancer cells.

Main Results:

• Successfully created a genetic sensor capable of detecting WTP53 expression within cells.
• Engineered a system combining the p53 sensor and diphtheria toxin for targeted cancer cell elimination.
• Demonstrated the potential for specific killing of p53-deficient tumor cells.

Conclusions:

• The study presents a novel p53 genetic sensor for WTP53 detection.
• A new therapeutic approach for cancer treatment based on a p53 genetic sensor and diphtheria toxin was developed.
• This work offers a promising strategy for targeting cancers by leveraging p53 protein characteristics.